These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7422097)

  • 1. Preferential inhibition of type B-MAO by new compounds, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1h-indazole(Fs32) and its N-desmethylated derivative (FS97).
    Koide T; Uyemura K
    Neuropharmacology; 1980 Sep; 19(9):871-5. PubMed ID: 7422097
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of a chronic new potential antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole(FS32) and its N-desmethylated compound(FS97): treatment on monoaminergic receptor sensitivity in the rat brain.
    Koide T; Matsushita H
    Neuropharmacology; 1981 Mar; 20(3):285-92. PubMed ID: 7266786
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of (3H)-dopamine uptake into rat brain synaptosomes by the new non-tricyclic antidepressants, FS32 and FS97.
    Koide T; Uyemura K
    Eur J Pharmacol; 1980 Mar; 62(2-3):147-55. PubMed ID: 7379837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the inhibitory effects of new non-tricyclic amine uptake inhibitors on the uptake of norepinephrine and 5-hydroxytryptamine into synaptosomes of the rat brain.
    Koide T; Uyemura K
    Neuropharmacology; 1980 Apr; 19(4):349-54. PubMed ID: 7383280
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of monoamine oxidases. Inhibition of bovine brain MAO in intact mitochondria by tricyclic antidepressant drugs.
    Achee FM; Gabay S
    Biochem Pharmacol; 1979 Apr; 28(7):1197-203. PubMed ID: 444277
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological studies on a new thymoleptic antidepressant, 1-[3-(dimethylamino)propyl]-5-methyl-3-phenyl-1H-indazole (FS-32).
    Ikeda Y; Takano N; Matsushita H; Shiraki Y; Koide T; Nagashima R; Fujimura Y; Shindo M; Suzuki S; Iwasaki T
    Arzneimittelforschung; 1979; 29(3):511-20. PubMed ID: 114190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors.
    Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M
    Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
    Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
    Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human brain type B monoamine oxidase by tricyclic psychoactive drugs.
    Roth JA
    Mol Pharmacol; 1978 Jan; 14(1):164-71. PubMed ID: 24168
    [No Abstract]   [Full Text] [Related]  

  • 11. Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency.
    Tzvetkov NT; Hinz S; Küppers P; Gastreich M; Müller CE
    J Med Chem; 2014 Aug; 57(15):6679-703. PubMed ID: 24955776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and selective inhibitory activity of 1-acetyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives against monoamine oxidase.
    Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Befani O; Turini P; Giovannini V; Mondovì B; Cirilli R; La Torre F
    J Med Chem; 2004 Apr; 47(8):2071-4. PubMed ID: 15056004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine.
    Takamidoh H; Naoi M; Nagatsu T
    Neurosci Lett; 1987 Jan; 73(3):293-7. PubMed ID: 3494215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of monoamine oxidase by tricyclic antidepressants: the influence of the nature of the substrate and the source of the enzyme.
    Green AL; McGachy HA
    J Pharm Pharmacol; 1987 May; 39(5):392-4. PubMed ID: 2886590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T; Aomine M
    Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123(1-6):13-26. PubMed ID: 22032088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the biological pharmacology of IFO, a new selective and reversible monoamine oxidase-B inhibitor.
    Matsumoto J; Takahashi T; Agata M; Toyofuku H; Sasada N
    Jpn J Pharmacol; 1994 May; 65(1):51-7. PubMed ID: 8089930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of rat brain monoamine oxidase and succinic dehydrogenase by anticonvulsant pyrazolines.
    Soni N; Pande K; Kalsi R; Gupta TK; Parmar SS; Barthwal JP
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):129-32. PubMed ID: 3589148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
    Herraiz T; Arán VJ; Guillén H
    Free Radic Res; 2009 Oct; 43(10):975-84. PubMed ID: 19669997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (+)-4-Dimethylamino-2,alpha-dimethylphenethylamine (FLA 336(+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain.
    Ask AL; Högberg K; Schmidt L; Kiessling H; Ross SB
    Biochem Pharmacol; 1982 Apr; 31(7):1401-6. PubMed ID: 7092929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T; Aomine M
    Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123():13-26. PubMed ID: 25022028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.